Loading article…
CFPB seeks to convert Synapse bankruptcy to Chapter 7 and tap its $118.9 M penalty fund to reimburse $60‑90 M missing fintech customer funds.
The Consumer Financial Protection Bureau filed a supplemental declaration on Friday urging the Central California court to convert Synapse’s Chapter 11 case to Chapter 7, a step that would let the agency draw on its Civil Penalty Fund to compensate fintech users still owed $60‑90 million after the BaaS provider’s April 2024 bankruptcy [3].
| At a glance | |
|---|---|
| Missing customer funds | $60‑90 million estimated shortfall |
| CFPB remedy | Nominal $1 civil penalty to unlock Civil Penalty Fund |
| Fund balance | $118.9 million unallocated as of Sep 30 2024 |
| Bankruptcy status | Request to convert from Chapter 11 to Chapter 7 |
The bureau’s filing, prepared with trustee Jelena McWilliams, alleges Synapse failed to keep adequate records of consumer funds and did not reconcile those records with partner banks, leaving thousands of fintech customers without access to their money [3]. By converting the case to Chapter 7, the CFPB would gain a “Stipulated Judgment” that includes a $1 civil penalty—just enough to qualify the case for distributions from the agency’s Civil Penalty Fund, which currently holds $118.9 million of unused money [2].
When Synapse collapsed, partner banks such as Evolve, Lineage, AMG National Trust and American returned only part of the deposits, leaving a shortfall of $60‑90 million that remains unrecovered [1][3]. The CFPB’s intervention does not guarantee full restitution; the amount each victim receives will depend on the fund’s remaining balance and the agency’s allocation methodology [1]. Nonetheless, the move could provide a path to recovery that the bankrupt estate alone cannot, given its depleted assets.
Analysts note the action may benefit fintechs like Yotta, Juno and Copper, which previously relied on Synapse’s middleware and suffered the biggest losses [1]. Critics argue the timing reflects political considerations rather than pure consumer protection, pointing to the agency’s historically limited enforcement under the current administration [1]. Regardless of motive, the filing signals a willingness to use regulatory tools to address gaps in the banking‑as‑a‑service model.
The CFPB’s push to convert Synapse’s case and tap its penalty fund underscores growing regulatory scrutiny of BaaS providers, while leaving open how much of the $60‑90 million shortfall will ultimately reach affected fintech users.
Coverage is mostly measured — 8 of 8 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 3 outlets · Jun 18, 2026 · How we report
A report by trustee Jelena McWilliams indicates an $85 million discrepancy between the $265 million in customer balances and the $180 million held by partner banks, but the exact source of the missing funds is still unknown.
More than 100,000 customers of various fintech companies that used Synapse have been locked out of their savings accounts.
The trial showed consistent signals of benefit in functional endpoints, including improved hand grip strength and motor function, with effects persisting up to seven days after treatment ended.
Ignaseclant was reported as well tolerated, with all adverse events classified as mild or moderate and no serious adverse events or discontinuations.
NMD Pharma plans to conduct larger and longer-term studies to further evaluate ignaseclant’s efficacy and safety in Charcot‑Marie‑Tooth disease.